Azam Usman bought CUE

September 29, 2025 · Form 4 insider transaction

Azam Usman bought 1,875,000 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.

Direction

Acquired (buy-side)

1,875,000

Price

$0.00

Total value

N/A

InsiderAzam Usman

RoleOfficer, Director

CompanyCue Biopharma, Inc. (CUE)

SecurityStock Option (right to buy)

Transaction codeA — Grant or award

Transaction dateSeptember 29, 2025

Filing dateOctober 2, 2025

Shares owned after1,875,000

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

This stock option becomes exercisable in 48 monthly installments beginning on September 29, 2026.

View the original Form 4 on SEC EDGAR